Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 2 Sarcoma 1

Conditions

Sarcoma 1 Neoplasm Metastasis 1

Interventions

Cyclophosphamide 55 Specimen Handling 50 Magnetic Resonance Spectroscopy 49 Doxorubicin 44 pembrolizumab 43 Radiotherapy 42 Temozolomide 38 Biopsy 34 Radiation 29 Nivolumab 28 fludarabine 23 Vincristine 22 Irinotecan 21 Gemcitabine 21 X-Rays 20 Ifosfamide 20 Surgical Procedures, Operative 19 atezolizumab 17 cabozantinib 15 Ipilimumab 15 olaparib 13 Sunitinib 13 Paclitaxel 13 Etoposide 13 Blood Specimen Collection 13 regorafenib 12 fludarabine phosphate 12 Phantoms, Imaging 12 Imatinib Mesylate 12 liposomal doxorubicin 11

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

glasdegib × Sarcoma × 1 year × Clear all

NCT03784014 2026-04-29

MULTISARC

Institut National de la Santé Et de la Recherche Médicale, France

Phase 3 Completed

Neoplasm Metastasis, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡